Eun-Hae Cho Selected Research

Therapeutics

1/2020	Genetic heterogeneity and prognostic impact of recurrent ANK2 and TP53 mutations in mantle cell lymphoma: a multi-centre cohort study.
10/2012	A case of 9.7 Mb terminal Xp deletion including OA1 locus associated with contiguous gene syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eun-Hae Cho Research Topics

Disease

5	Brain Injuries (Brain Injury) 11/2012 - 01/2009
4	Neoplasms (Cancer) 01/2022 - 04/2019
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2012 - 01/2009
2	Genomic Instability 10/2021 - 04/2019
2	Brain Ischemia (Cerebral Ischemia) 11/2012 - 06/2010
2	Ischemia 06/2012 - 11/2010
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Homocystinuria 11/2021
1	Methylmalonic acidemia 11/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Esophageal Squamous Cell Carcinoma 01/2021
1	Residual Neoplasm 01/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020
1	Aneuploidy (Aneuploid) 09/2019
1	Hepatocellular Carcinoma (Hepatoma) 04/2019
1	Hepatolenticular Degeneration (Wilson's Disease) 09/2017
1	Kallmann Syndrome (Kallmann's Syndrome) 09/2017
1	Anosmia 09/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017
1	Leri-Weil syndrome 10/2012
1	Reperfusion Injury 11/2010
1	Infarction (Infarctions) 01/2009

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2019
4	Proteins (Proteins, Gene)FDA Link 11/2012 - 04/2009
2	Circulating Tumor DNAIBA 01/2022 - 10/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2021
2	Cell-Free Nucleic AcidsIBA 01/2021 - 04/2019
2	Ginkgo biloba extract (Rokan)IBA 06/2012 - 01/2009
2	Neuroprotective AgentsIBA 06/2012 - 04/2009
2	MelatoninIBA 11/2010 - 04/2009
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	PlatinumIBA 01/2022
1	olaparibIBA 01/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 11/2021
1	dichlorobis(azomycin)platinum IIIBA 09/2019
1	Sorafenib (BAY 43-9006)FDA Link 04/2019
1	A-Form DNA (A-DNA)IBA 09/2017
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	EnzymesIBA 11/2012
1	ferulic acid (sodium ferulate)IBA 11/2012
1	Growth Hormone (Somatotropin)IBA 10/2012
1	ParvalbuminsIBA 06/2012
1	Estradiol (Delestrogen)FDA LinkGeneric 06/2010

Therapy/Procedure

2	Therapeutics 01/2020 - 10/2012
1	Secondary Prevention 01/2022
1	Chemoradiotherapy 01/2021